Low dose of sitagliptin: effectively prevent liver aGVHD and accelerate neutrophil engraftment.

Ann Hematol · 2026 · PMC13128724 · PMID 42053786

Europe PMC DOI

hedged sentences

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

showed a trendp = 0.078so close (0.05 < p ≤ 0.1)

In univariate analysis, sitagliptin use showed a trend toward reduced incidence of liver aGVHD (OR 0.141, 95% CI 0.016–1.242, p = 0.078).

also in 53,322 other papers

did not reach statistical significanceno p-value reported

18.2%, p = 0.258) but did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.